Evidence map›Paper›PMID 42346166›Full record

ReviewEpidemiologia (Basel, Switzerland)2026

From Ebola to H5N1: Strengthening the U.S. Special Pathogen Response System.

Anthony Joseph Lo Piccolo, Erin McGuire, Radu Postelnicu, Kathryn Jano, Ryan Leone, Eliana Jacobson, Angela Vasa, Michelle Schwedhelm, Vikramjit Mukherjee

Abstract readReview
In one paragraph

Review in Epidemiologia (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Anthony Joseph Lo PiccoloDepartment of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0001-5618-8645
Erin McGuireDepartment of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
Radu PostelnicuDepartment of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
Kathryn JanoNew York Medical College School of Medicine, Touro University, Valhalla, NY 10595, USA.ORCID 0009-0008-8084-6941
Ryan LeoneVagelos College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.ORCID 0000-0003-0549-9990
Eliana JacobsonDepartment of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.ORCID 0000-0001-5360-6223
Angela VasaEmergency Preparedness and Special Pathogen Programs, Nebraska Medical Center: Global Center for Health Security Scholar, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0000-0003-3473-5905
Michelle SchwedhelmEmergency Management and Clinical Operations, University of Nebraska Medical Center, Omaha, NE 68198, USA.ORCID 0009-0006-0310-6371
Vikramjit MukherjeeDepartment of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.

Funding

Administration for Strategic Preparedness and Response U3REP150549Administration for Strategic Preparedness and Response U3REP220682
6 · The paper itself

Abstract

The National Special Pathogens System (NSPS) stratifies U.S. healthcare facilities by their readiness level to care for patients with high-consequence infectious diseases (HCIDs). While NSPS Level 1 and 2 facilities possess advanced biocontainment capabilities to care for patients for the duration of their illness, most U.S. hospitals fall under a NSPS Level 3 or 4 designation, with limited resources to manage patients with a suspected or confirmed HCID. However, emerging zoonotic threats like H5N1 underscore the need to bolster HCID preparedness across all NSPS Levels. Beginning in March 2024, the U.S. H5N1 outbreak has primarily impacted wild bird flocks, poultry, and cattle, along with some human infections. The continuation of this outbreak in wild and domesticated animals increases the likelihood of further human spillover and eventual viral evolution in human hosts. At the frontlines, rural farming communities are likely to be most affected, with potential outbreaks exacerbated by a lack of accessible NSPS Level 1, 2, or 3 facilities in these regions. Thus, strengthening the HCID preparedness of local NSPS Level 4 facilities is critical to preventing transmission, minimizing societal disruption, protecting communities and the healthcare workforce, along with ensuring an equitable, coordinated response to future emerging infectious disease threats. This manuscript explores the financial, societal and health system impacts of HCID outbreaks to delineate the necessity of strengthening the preparedness of NSPS Level 4 facilities.

Indexed as

Ebola virusfrontline hospitalsH5N1HCIDhigh-consequence infectious diseasesNETECNSPSpandemic preparednessRESPTCspecial pathogens

Identifiers

PMID42346166
PMCPMC13297867

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.